A carregar...
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
Inhibition of the MDM2/X-p53 interaction is recognized as a potential anti-cancer strategy, including the treatment of glioblastoma (GB). In response to cellular stressors, such as DNA damage, the tumor suppression protein p53 is activated and responds by mediating cellular damage through DNA repair...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8296304/ https://ncbi.nlm.nih.gov/pubmed/34307171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.703442 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|